Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma
出版年份 2015 全文链接
标题
Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma
作者
关键词
-
出版物
JNCI-Journal of the National Cancer Institute
Volume 107, Issue 8, Pages -
出版商
Oxford University Press (OUP)
发表日期
2015-05-30
DOI
10.1093/jnci/djv132
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- FOLFIRINOX – a new paradigm in the treatment of pancreatic cancer
- (2014) Dionysios Papadatos-Pastos et al. Expert Review of Anticancer Therapy
- Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design
- (2013) Matthew H. G. Katz et al. ANNALS OF SURGICAL ONCOLOGY
- A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer
- (2013) A H Ko et al. BRITISH JOURNAL OF CANCER
- Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study
- (2013) R. P. Jones et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Human Carboxylesterase-2 Hydrolyzes the Prodrug of Gemcitabine (LY2334737) and Confers Prodrug Sensitivity to Cancer Cells
- (2013) S. E. Pratt et al. CLINICAL CANCER RESEARCH
- Clinical implications of CES2 RNA expression in neuroblastoma
- (2013) Keiichi Uchida et al. JOURNAL OF PEDIATRIC SURGERY
- Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy
- (2012) Ching-Wei D. Tzeng et al. ANNALS OF SURGICAL ONCOLOGY
- Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
- (2012) Matthew H. G. Katz et al. CANCER
- The pharmacological landscape and therapeutic potential of serine hydrolases
- (2012) Daniel A. Bachovchin et al. NATURE REVIEWS DRUG DISCOVERY
- Detection and Quantification of Carboxylesterase 2 Activity by Capillary Electrophoresis
- (2011) Joana Lamego et al. ANALYTICAL CHEMISTRY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11
- (2010) M. Jason Hatfield et al. BIOCHEMICAL PHARMACOLOGY
- Activity-based Proteomics of Enzyme Superfamilies: Serine Hydrolases as a Case Study
- (2010) Gabriel M. Simon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis
- (2009) Daniel K. Nomura et al. CELL
- Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice
- (2009) Michael P Kim et al. Nature Protocols
- RBBP9: A tumor-associated serine hydrolase activity required for pancreatic neoplasia
- (2009) D. J. Shields et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of an Integrated Biospecimen Bank and Multidisciplinary Clinical Database For Pancreatic Cancer
- (2008) Rosa F. Hwang et al. ANNALS OF SURGICAL ONCOLOGY
- Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma
- (2008) Hiroki Yano et al. CANCER SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now